rs149152116

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The ENST00000425018.1(TUBGCP6):​c.1165C>T​(p.Arg389Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00313 in 1,612,482 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R389H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0020 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0032 ( 11 hom. )

Consequence

TUBGCP6
ENST00000425018.1 missense

Scores

3
11

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.308

Publications

0 publications found
Variant links:
Genes affected
TUBGCP6 (HGNC:18127): (tubulin gamma complex component 6) The protein encoded by this gene is part of a large multisubunit complex required for microtubule nucleation at the centrosome. [provided by RefSeq, Jul 2008]
TUBGCP6 Gene-Disease associations (from GenCC):
  • microcephaly and chorioretinopathy 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009924054).
BP6
Variant 22-50218218-G-A is Benign according to our data. Variant chr22-50218218-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 437142.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00204 (311/152320) while in subpopulation NFE AF = 0.00347 (236/68020). AF 95% confidence interval is 0.00311. There are 2 homozygotes in GnomAd4. There are 142 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TUBGCP6NM_020461.4 linkc.5139C>T p.His1713His synonymous_variant Exon 23 of 25 ENST00000248846.10 NP_065194.3 Q96RT7-1
TUBGCP6XR_938347.3 linkn.*78C>T downstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TUBGCP6ENST00000248846.10 linkc.5139C>T p.His1713His synonymous_variant Exon 23 of 25 1 NM_020461.4 ENSP00000248846.5 Q96RT7-1

Frequencies

GnomAD3 genomes
AF:
0.00204
AC:
311
AN:
152202
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000748
Gnomad AMI
AF:
0.0110
Gnomad AMR
AF:
0.000981
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00228
Gnomad FIN
AF:
0.000377
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00347
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.00210
AC:
523
AN:
249006
AF XY:
0.00217
show subpopulations
Gnomad AFR exome
AF:
0.000870
Gnomad AMR exome
AF:
0.00148
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000380
Gnomad NFE exome
AF:
0.00329
Gnomad OTH exome
AF:
0.00230
GnomAD4 exome
AF:
0.00325
AC:
4743
AN:
1460162
Hom.:
11
Cov.:
37
AF XY:
0.00319
AC XY:
2318
AN XY:
726422
show subpopulations
African (AFR)
AF:
0.000807
AC:
27
AN:
33476
American (AMR)
AF:
0.00145
AC:
65
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
0.0000766
AC:
2
AN:
26110
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39692
South Asian (SAS)
AF:
0.00194
AC:
167
AN:
86252
European-Finnish (FIN)
AF:
0.000385
AC:
20
AN:
51944
Middle Eastern (MID)
AF:
0.00191
AC:
11
AN:
5768
European-Non Finnish (NFE)
AF:
0.00387
AC:
4307
AN:
1111844
Other (OTH)
AF:
0.00239
AC:
144
AN:
60370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
326
653
979
1306
1632
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
170
340
510
680
850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00204
AC:
311
AN:
152320
Hom.:
2
Cov.:
33
AF XY:
0.00191
AC XY:
142
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.000746
AC:
31
AN:
41572
American (AMR)
AF:
0.000980
AC:
15
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00228
AC:
11
AN:
4830
European-Finnish (FIN)
AF:
0.000377
AC:
4
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00347
AC:
236
AN:
68020
Other (OTH)
AF:
0.00142
AC:
3
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
18
35
53
70
88
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00266
Hom.:
0
Bravo
AF:
0.00210
TwinsUK
AF:
0.00324
AC:
12
ALSPAC
AF:
0.00545
AC:
21
ESP6500AA
AF:
0.000681
AC:
3
ESP6500EA
AF:
0.00477
AC:
41
ExAC
AF:
0.00200
AC:
243
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.00387
EpiControl
AF:
0.00314

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
-
Clinical Genetics, Academic Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 02, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 01, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

TUBGCP6: BP4, BP7, BS2 -

not specified Benign:1
Jul 16, 2018
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Microcephaly and chorioretinopathy 1 Benign:1
Jun 28, 2017
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.45
T
BayesDel_noAF
Benign
-0.42
CADD
Benign
0.016
DANN
Benign
0.90
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.18
N
LIST_S2
Benign
0.35
T
MetaRNN
Benign
0.0099
T
MetaSVM
Benign
-0.75
T
PhyloP100
-0.31
PROVEAN
Uncertain
-2.5
D
REVEL
Benign
0.27
Sift
Uncertain
0.0080
D
Sift4G
Uncertain
0.022
D
MVP
0.072
ClinPred
0.027
T
GERP RS
-7.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs149152116; hg19: chr22-50656647; COSMIC: COSV107216535; COSMIC: COSV107216535; API